PMC:7195088 / 9007-9411 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"164","span":{"begin":20,"end":28},"obj":"Species"},{"id":"165","span":{"begin":174,"end":182},"obj":"Species"},{"id":"166","span":{"begin":188,"end":198},"obj":"Species"},{"id":"167","span":{"begin":379,"end":387},"obj":"Species"},{"id":"231","span":{"begin":34,"end":54},"obj":"Disease"},{"id":"232","span":{"begin":239,"end":251},"obj":"Disease"},{"id":"233","span":{"begin":273,"end":284},"obj":"Disease"},{"id":"234","span":{"begin":330,"end":339},"obj":"Disease"},{"id":"235","span":{"begin":370,"end":378},"obj":"Disease"}],"attributes":[{"id":"A164","pred":"tao:has_database_id","subj":"164","obj":"Tax:9606"},{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"Tax:9606"},{"id":"A166","pred":"tao:has_database_id","subj":"166","obj":"Tax:2697049"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"Tax:9606"},{"id":"A231","pred":"tao:has_database_id","subj":"231","obj":"MESH:C000657245"},{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"MESH:D007249"},{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"MESH:D055370"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"MESH:D011014"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":256,"end":264},"obj":"Body_part"},{"id":"T2","span":{"begin":273,"end":277},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":273,"end":277},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":330,"end":339},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":34,"end":42},"obj":"Disease"},{"id":"T40","span":{"begin":45,"end":54},"obj":"Disease"},{"id":"T41","span":{"begin":188,"end":192},"obj":"Disease"},{"id":"T42","span":{"begin":239,"end":251},"obj":"Disease"},{"id":"T43","span":{"begin":278,"end":284},"obj":"Disease"},{"id":"T44","span":{"begin":330,"end":339},"obj":"Disease"},{"id":"T45","span":{"begin":370,"end":378},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T29","span":{"begin":273,"end":277},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T30","span":{"begin":273,"end":277},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40","span":{"begin":148,"end":162},"obj":"Chemical"}],"attributes":[{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":239,"end":251},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}

{"project":"LitCovid-sentences","denotations":[{"id":"T64","span":{"begin":56,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d administration in patients with SARS-CoV-2 infection. As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (exp"}